Literature DB >> 30530859

Changes in Endogenous Dopamine Induced by Methylphenidate Predict Functional Connectivity in Nonhuman Primates.

Rasmus M Birn1,2, Alexander K Converse3, Abigail Z Rajala4, Andrew L Alexander1,4,2, Walter F Block2,5, Alan B McMillan6, Bradley T Christian3,2, Caitlynn N Filla4, Dhanabalan Murali2, Samuel A Hurley6, Rick L Jenison4,7, Luis C Populin8.   

Abstract

Dopamine (DA) levels in the striatum are increased by many therapeutic drugs, such as methylphenidate (MPH), which also alters behavioral and cognitive functions thought to be controlled by the PFC dose-dependently. We linked DA changes and functional connectivity (FC) using simultaneous [18F]fallypride PET and resting-state fMRI in awake male rhesus monkeys after oral administration of various doses of MPH. We found a negative correlation between [18F]fallypride nondisplaceable binding potential (BPND) and MPH dose in the head of the caudate (hCd), demonstrating increased extracellular DA resulting from MPH administration. The decreased BPND was negatively correlated with FC between the hCd and the PFC. Subsequent voxelwise analyses revealed negative correlations with FC between the hCd and the dorsolateral PFC, hippocampus, and precuneus. These results, showing that MPH-induced changes in DA levels in the hCd predict resting-state FC, shed light on a mechanism by which changes in striatal DA could influence function in the PFC.SIGNIFICANCE STATEMENT Dopamine transmission is thought to play an essential role in shaping large scale-neural networks that underlie cognitive functions. It is the target of therapeutic drugs, such as methylphenidate (Ritalin), which blocks the dopamine transporter, thereby increasing extracellular dopamine levels. Methylphenidate is used extensively to treat attention deficit hyperactivity disorder, even though its effects on cognitive functions and their underlying neural mechanisms are not well understood. To date, little is known about the link between changes in dopamine levels and changes in functional brain organization. Using simultaneous PET/MR imaging, we show that methylphenidate-induced changes in endogenous dopamine levels in the head of the caudate predict changes in resting-state functional connectivity between this structure and the prefrontal cortex, precuneus, and hippocampus.
Copyright © 2019 the authors 0270-6474/19/391437-09$15.00/0.

Entities:  

Keywords:  PET/MR; dopamine; fallypride; methylphenidate

Mesh:

Substances:

Year:  2018        PMID: 30530859      PMCID: PMC6381257          DOI: 10.1523/JNEUROSCI.2513-18.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  56 in total

1.  Genetic variation in dopaminergic neuromodulation influences the ability to rapidly and flexibly adapt decisions.

Authors:  Lea K Krugel; Guido Biele; Peter N C Mohr; Shu-Chen Li; Hauke R Heekeren
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-12       Impact factor: 11.205

2.  Functional dysconnectivity of corticostriatal circuitry and differential response to methylphenidate in youth with attention-deficit/hyperactivity disorder.

Authors:  Soon-Beom Hong; Ben J Harrison; Alex Fornito; Chul-Ho Sohn; In-Chan Song; Jae-Won Kim
Journal:  J Psychiatry Neurosci       Date:  2015-01       Impact factor: 6.186

3.  PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects.

Authors:  T E Schlaepfer; G D Pearlson; D F Wong; S Marenco; R F Dannals
Journal:  Am J Psychiatry       Date:  1997-09       Impact factor: 18.112

Review 4.  Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates.

Authors:  B Berger; P Gaspar; C Verney
Journal:  Trends Neurosci       Date:  1991-01       Impact factor: 13.837

5.  An FMRI study of the effects of psychostimulants on default-mode processing during Stroop task performance in youths with ADHD.

Authors:  Bradley S Peterson; Marc N Potenza; Zhishun Wang; Hongtu Zhu; Andrés Martin; Rachel Marsh; Kerstin J Plessen; Shan Yu
Journal:  Am J Psychiatry       Date:  2009-09-15       Impact factor: 18.112

6.  Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography.

Authors:  Y Ouchi; E Yoshikawa; H Okada; M Futatsubashi; Y Sekine; M Iyo; M Sakamoto
Journal:  Ann Neurol       Date:  1999-05       Impact factor: 10.422

7.  The distribution of D2/D3 receptor binding in the adolescent rhesus monkey using small animal PET imaging.

Authors:  Bradley T Christian; Nicholas T Vandehey; Andrew S Fox; Dhanabalan Murali; Terrence R Oakes; Alex K Converse; Robert J Nickles; Steve E Shelton; Richard J Davidson; Ned H Kalin
Journal:  Neuroimage       Date:  2008-10-29       Impact factor: 6.556

Review 8.  Positron emission tomography neuroimaging for a better understanding of the biology of ADHD.

Authors:  Luc Zimmer
Journal:  Neuropharmacology       Date:  2009-08-13       Impact factor: 5.250

9.  Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals.

Authors:  Nigel S Bamford; Hui Zhang; Yvonne Schmitz; Nan-Ping Wu; Carlos Cepeda; Michael S Levine; Claudia Schmauss; Stanislav S Zakharenko; Leonard Zablow; David Sulzer
Journal:  Neuron       Date:  2004-05-27       Impact factor: 17.173

10.  Interhemispheric correlations of slow spontaneous neuronal fluctuations revealed in human sensory cortex.

Authors:  Yuval Nir; Roy Mukamel; Ilan Dinstein; Eran Privman; Michal Harel; Lior Fisch; Hagar Gelbard-Sagiv; Svetlana Kipervasser; Fani Andelman; Miri Y Neufeld; Uri Kramer; Amos Arieli; Itzhak Fried; Rafael Malach
Journal:  Nat Neurosci       Date:  2008-09       Impact factor: 24.884

View more
  7 in total

Review 1.  Advances in simultaneous PET/MR for imaging neuroreceptor function.

Authors:  Christin Y Sander; Hanne D Hansen; Hsiao-Ying Wey
Journal:  J Cereb Blood Flow Metab       Date:  2020-03-13       Impact factor: 6.200

2.  β-adrenergic modulation of discrimination learning and memory in the auditory cortex.

Authors:  Horst Schicknick; Julia U Henschke; Eike Budinger; Frank W Ohl; Eckart D Gundelfinger; Wolfgang Tischmeyer
Journal:  Eur J Neurosci       Date:  2019-07-01       Impact factor: 3.386

Review 3.  Adipose tissue, systematic inflammation, and neurodegenerative diseases.

Authors:  Ana Paula de A Boleti; Pedro Henrique de O Cardoso; Breno Emanuel F Frihling; Patrícia Souza E Silva; Luiz Filipe R N de Moraes; Ludovico Migliolo
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

4.  Cognitive enhancement: Effects of methylphenidate, modafinil, and caffeine on latent memory and resting state functional connectivity in healthy adults.

Authors:  Maxi Becker; Dimitris Repantis; Martin Dresler; Simone Kühn
Journal:  Hum Brain Mapp       Date:  2022-06-07       Impact factor: 5.399

5.  Methylphenidate affects task-switching and neural signaling in non-human primates.

Authors:  Abigail Z Rajala; Luis C Populin; Rick L Jenison
Journal:  Psychopharmacology (Berl)       Date:  2020-02-18       Impact factor: 4.530

6.  Amisulpride and l-DOPA modulate subcortical brain nuclei connectivity in resting-state pharmacologic magnetic resonance imaging.

Authors:  Oliver Grimm; Vera Kopfer; Lea Küpper-Tetzel; Vera Deppert; Magdalena Kuhn; Moritz de Greck; Andreas Reif
Journal:  Hum Brain Mapp       Date:  2019-12-27       Impact factor: 5.038

7.  Brain opioid segments and striatal patterns of dopamine release induced by naloxone and morphine.

Authors:  Ehsan Shokri-Kojori; Mika Naganawa; Vijay A Ramchandani; Dean F Wong; Gene-Jack Wang; Nora D Volkow
Journal:  Hum Brain Mapp       Date:  2021-12-07       Impact factor: 5.038

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.